Security key
12674W109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 38,433,072
- Total 13F value
- $87,226,012
- Share change
- -9,933,273
- Put/Call ratio
- 33%
- SEC-reported price per share
- $2.27
- Number of holders
- 104
- Value change
- -$42,983,423
- Number of buys
- 57
- Number of sells
- 61
- Shares outstanding
- 163,302,815
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
104
Top holders
10
CABA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Cabaletta Bio, Inc. SEC filings
Cabaletta Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 12674W109
Recent filing periods:
Ownership snapshot
Top reported holders of CABA - Cabaletta Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JENNISON ASSOCIATES LLC
Disclosed value leader
JENNISON ASSOCIATES LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 3.4%
Showing 1-6 of 15 holder rows.
Quick read
JENNISON ASSOCIATES LLC leads the comparable SEC ownership view at 3.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JENNISON ASSOCIATES LLC's linked filing trail.
Comparable ownership
Top 5
JENNISON ASSOCIATES LLC
3.4%
BlackRock, Inc.
2.9%
FRED ALGER MANAGEMENT, LLC
2.5%
T. Rowe Price Investment Manageme...
2.2%
ADAGE CAPITAL PARTNERS GP, L.L.C.
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC |
13F
Company
|
3.4%
|
$26,586,255
5,632,681 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
2.9%
|
$22,625,244
4,793,484 shares
|
— | 30 Sep 2024 |
| FRED ALGER MANAGEMENT, LLC |
13F
Company
|
2.5%
|
$19,443,540
4,119,394 shares
|
— | 30 Sep 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
2.2%
|
$17,340,000
3,673,724 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.9%
|
$14,332,964
3,036,645 shares
|
— | 30 Sep 2024 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
1.7%
|
$13,031,391
2,760,888 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
104
Shares
38,433,072
Rows available
104
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
116
Q4 2024 holders
104
Holder diff
-12
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend